Beyond BioNTech and Moderna, will CureVac be the future leader in mRNA vaccines?

SOPHIA-ANTIPOLIS, France – February 01, 2021 | After three decades of research, mRNA-based vaccines have proven their safety and efficacy. They have finally reached the market, holding the promise to revolutionize the field. In December 2020, the FDA and EMA granted historic authorization to the first mRNA vaccine in the United States and in Europe.[…]

The advent of EV/HEV technology has acted as a catalyst for innovation, leading to an acceleration in applications for power module related patents

SOPHIA ANTIPOLIS, France – January 28, 2021 | The last decade has seen EV/HEV applications driving packaging innovation in power electronics and creating new equations to solve for module makers, in particular further downsizing, higher power density, higher reliability and lower cost/higher manufacturability. On top of that, automotive OEMs are asking for highly standardized power[…]

QuantumScape successfully goes public: its patent portfolio gives clues about its R&D developments

SOPHIA ANTIPOLIS, France – December 9, 2020 | QuantumScape is an American company founded in 2010, a spin-off from Stanford University. It develops new and advanced energy storage solutions, notably solid-state batteries. Volkswagen and QuantumScape have been collaborating since 2012. Volkswagen started to strengthen their partnership in 2018 by investing $100 million in QuantumScape. It[…]

The last 2 years marked a turning point for RF GaN patenting activity now driven by China and moving on technical issues further down the value chain.

SOPHIA ANTIPOLIS, France – November 6, 2020 | The radio frequency (RF) GaN market is experiencing impressive growth, mainly driven by telecom and military applications. Yole Développement predicts a GaN RF market increase from $740 million in 2019 to more than $2 billion in 2025, with a CAGR of 12%. According to market analysts, both[…]